The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 444 participants.
Also called NCT01278498
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose prevention
- Phase
- Phase 4
- Enrolled
- 444 participants
- Registry
-
NCT01278498
-
- Other papers using this trial's data
- Depressive Symptoms in Stroke Patients: Are There Sex Differences?
- Efficacy of early administration of escitalopram on depressive and emotional symptoms and neurological dysfunction after stroke: a multicentre, double-blind, randomised, placebo-controlled study
- Post-Stroke Depressive Symptoms: Varying Responses to Escitalopram by Individual Symptoms and Lesion Location
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01278498. Randomized; quadruple masking; primary purpose prevention. Start 2011-01 (registry gives no type); primary completion 2014-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Preventive Effect of Escitalopram on Depression and Related Emotional Disorders in Acute Stroke Patients
- Acronym
- EMOTION
- Condition
- Depression
- Intervention (Drug)
- Escitalopram
- Intervention (Drug)
- sugar pill
- Lead sponsor
- Asan Medical Center
- Collaborator
- Dong-A ST Co., Ltd.
Record details
- Record id
cardio:ct-nct01278498- Content hash
48ffc8c295053120ce790d06f539ac6febdcaa4276212456c6a8ed693c247dd6